Eurofins-Cerep S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALECR.PA research report →
About the company
Established in 1989 and headquartered in Vienne, France, Eurofins Cerep SA delivers a broad spectrum of drug discovery support to pharmaceutical and biotechnology enterprises across the globe. The company's specialized offerings include the management of chemical compounds, high-throughput screening capabilities, in vitro safety assessments, optimization of lead compounds (SAR profiling), in vitro ADME evaluations, and in vivo pharmacokinetic (PK) studies. Furthermore, it provides expert services in assay development and design.
- CEO
- Damien Vielliard
- IPO
- 2000
- Employees
- 209
- HQ
- Vienne, FR
Price Chart
- Market Cap
- $81.21M
- P/E
- 13.18
- P/S
- 2.09
- P/B
- 1.10
- EV/EBITDA
- 10.40
- Div Yield
- 0.00%
- Gross Margin
- 26.49%
- Op Margin
- 10.49%
- Net Margin
- 15.87%
- ROE
- 8.48%
- ROIC
- 5.38%
- Revenue
- $40.46M · -8.20%
- Net Income
- $7.15M · -6.34%
- EPS
- $1418.43 · -6.34%
- Op Income
- $4.50M
- FCF YoY
- 0.00%
- 52W High
- $20600.00
- 52W Low
- $15800.00
- 50D MA
- $17084.00
- 200D MA
- $18066.00
- Beta
- 0.03
- Avg Volume
- 0
Get TickerSpark's AI analysis on ALECR.PA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our ALECR.PA coverage
Recent articles, reports, and earnings notes.
No research on ALECR.PA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALECR.PA report →Similar companies
Peers in the same neighborhood.